AI disrupts protein design, a new era of developing drugs may be here
Professor David Baker, a pioneer in the field of artificially designed proteins, has published a new paper in Nature, in which his team has developed the AI software RFdiffusion, which can break through many of the previous limitations of protein design, and "customize" the design of proteins containing higher-order symmetric structures that could not be designed by AI in the past. The Nature press release states that the software can be customized to design proteins with high-order symmetric structures that could not be designed by AI before. According to a Nature press release, this AI model can design biomolecules on demand, potentially ushering in the next era of transformative vaccine and drug development. (Caixinhua News Agency)
人工设计蛋白领域先驱David Baker教授在《自然》发布最新论文，其团队所开发出的AI软件RFdiffusion能够突破既往诸多蛋白质设计限制，可根据需要“定制化”设计出包含高阶对称结构等以往无法通过AI设计的蛋白质。《自然》新闻稿指出，此AI模型可按需设计生物分子，将可能带来变革性疫苗和药物开发的下一个时代。（财联社）
Add comment
Comments